SINOPHARM (01099): Proposed appointment of Jin Bin and Li Ying as non-executive directors.

Sinopharm (01099) announced that Mr. Zhao Bingxiang has resigned from the positions of non-executive director, Chairman of the Board, Chairman of the Board Nomination Committee, Chairman of the Board Strategy and Investment Committee, Member of the Board Legal Compliance and Environment, Social and Governance Committee, and Company Authorized Representative as of November 28, 2025, due to work arrangements. Ms. Feng Rongli has also resigned from the positions of non-executive director, Member of the Board Compensation Committee, and Member of the Nomination Committee, effective from the date when their successors are appointed at the company's shareholders' meeting. On the same day, the Board of Directors has decided to appoint Mr. Jin Bin and Ms. Li Ying as non-executive directors. The Board of Directors hereby announces that on November 28, 2025, it has elected Mr. Jin as the Chairman of the Board and Authorized Representative. Mr. Jin's appointment as Chairman of the Board and Authorized Representative is subject to approval by the shareholders at the company's shareholders' meeting after being appointed as a non-executive director. Furthermore, the Board of Directors announced that on November 28, 2025, it has elected Mr. Jin as the Chairman of the Nomination Committee, Chairman of the Strategy and Investment Committee, and Member of the Legal Compliance and Environment, Social and Governance Committee. Mr. Jin's appointment to these positions is subject to approval by the shareholders at the company's shareholders' meeting after being appointed as a non-executive director.